Opko Health Inc OPK

NAS: OPK | ISIN: US68375N1037   1/07/2025
1,330 USD (+0,76%)
(+0,76%)   1/07/2025

11 maart 2025 · Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses · Persbericht

2 juli 2024 · NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner · Persbericht

28 maart 2024 · Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business · Persbericht

28 februari 2024 · NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st · Persbericht

5 februari 2024 · NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China · Persbericht

7 november 2023 · BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ · Persbericht

29 september 2023 · Thinking about buying stock in Blue Apron Holdings, OceanPal, OPKO Health, Bionomics, or Aytu Biopharma? · Persbericht

9 februari 2023 · BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings · Persbericht

16 maart 2022 · GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions · Persbericht

1 maart 2022 · Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease · Persbericht

29 november 2021 · BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S. · Persbericht

21 september 2021 · GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes · Persbericht

16 augustus 2021 · BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business · Persbericht

22 juni 2021 · BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry · Persbericht

27 april 2021 · Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year · Persbericht

1 april 2021 · BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball · Persbericht

26 maart 2021 · BioReference Laboratories Expands COVID-19 School Testing Program · Persbericht

3 februari 2021 · OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021 · Persbericht

26 januari 2021 · OPKO Health's GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia · Persbericht

26 januari 2021 · OPKO Health's BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing · Persbericht

Mijn selecties